On March 19 the Food and Drug Administration (FDA) issued letters of warning to two US breast implant manufacturers, Mentor Worldwide LLC and Sientra Inc.
The latest research by global technology research and advisory company Technavio predicts the global facial aesthetics market will be worth more than US $5.5 billion by 2020.
Laser manufacturer Lynton has partnered with Italian counterpart, DEKA to launch a new hair removal laser, the Motus AX.
Aesthetic practitioners from across the country gathered at the Crowne Plaza London City hotel on November 23 for the launch of the Biofibre Hair Implantation device.
Global pharmaceutical company Allergan has launched Juvéderm VOLUX, a hyaluronic acid injectable gel that uses the existing VYCROSS patented technology.
Medical device company, Theradome Inc, has received clearance from the Food and Drug Administration (FDA) for its LH80 PRO hair restoration device for men.
International pharmaceutical company Galderma has increased its investment in research and innovation, initiating six new Phase III and IV US aesthetic clinical trials.
A treatment for stretch marks that has been approved by the Food and Drug Administration (FDA) has been released to the public in the US.
Global pharmaceutical company Allergan has announced plans to build a USD $14.7 million centre to promote medical aesthetics innovations in Chengdu, China, which will train 3,000 practitioners per year.
Global pharmaceutical company Allergan has received US Food and Drug Administration (FDA) approval for the use of Juvéderm VOLUMA XC with a TSK STERiGLIDE cannula for cheek augmentation to correct age-related volume definition in the mid-face in adults over 21.